SCHEMBL8105255

SCHEMBL8105255

O=C(O)C(O)=CC(=O)c1ccc(F)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.58
TNFRSF1A P19438 1/20 0.50
CES2 O00748 1/20 0.48
CES1 P23141 1/20 0.48
CYP1A2 P05177 2/20 0.47
CYP2C19 P33261 2/20 0.47
BCL2L1 Q07817 1/20 0.47
BAD Q92934 1/20 0.47
CA1 P00915 2/20 0.45
CA2 P00918 2/20 0.45
ALDH1A1 P00352 3/20 0.44
KDM4E B2RXH2 1/20 0.44
HPGD P15428 1/20 0.44
HTT P42858 1/20 0.42
NFE2L2 Q16236 1/20 0.42
PTGS2 P35354 1/20 0.41
AKR1C2 P52895 1/20 0.41
AKR1C1 Q04828 1/20 0.41
AKR1C3 P42330 1/20 0.41
CYP3A4 P08684 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13864066 0.81 NFE2L2 (0.65) MAPTTNFRSF1ACES2CES1CYP1A2
SCHEMBL3305728 0.80 NFE2L2 (0.64) MAPTTNFRSF1ACES2CES1CA1
SCHEMBL3305717 0.80 NFE2L2 (0.64) MAPTTNFRSF1ACES2CES1CA1
SCHEMBL3305722 0.80 NFE2L2 (0.64) MAPTTNFRSF1ACES2CES1CA1
SCHEMBL11713737 0.80 MAPT (0.59) MAPTTNFRSF1ACES2CES1CYP1A2
SCHEMBL3310067 0.79 CYP1A2 (0.55) MAPTCES2CES1CYP1A2CA1
SCHEMBL3305322 0.79 CES2 (0.48) MAPTCES2CES1CA1ALDH1A1
SCHEMBL20673437 0.79 ALDH1A1 (0.59) MAPTCES2CES1ALDH1A1KDM4E
SCHEMBL3305324 0.79 CES2 (0.48) MAPTCES2CES1CA1ALDH1A1
SCHEMBL8089458 0.79 ALOX15 (0.52) MAPTCES2CES1CYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6048896-A FOR TREATMENT OF BRAIN OR NERVOUS SYSTEM DISORDERS PHARMACIA & UPJOHN S.P.A. (IT) 2000-04-11 US disclosed
EP-0858442-A1 4-PHENYL-4-OXO-2-BUTENOIC ACID DERIVATIVES WITH KYNURENINE-3-HYDROXYLASE INHIBITING ACTIVITY PHARMACIA & UPJOHN S.p.A. (IT) 1998-08-19 EP disclosed
WO-1997017316-A1 4-PHENYL-4-OXO-2-BUTENOIC ACID DERIVATIVES WITH KYNURENINE-3-HYDROXYLASE INHIBITING ACTIVITY PHARMACIA & UPJOHN S.P.A. (IT) 1997-05-15 WO disclosed